Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Niuxi Wenjing Tang is a Traditional Chinese Medicine (TCM) formula used to treat gynecological disorders characterized by cold in the uterus and blood stasis. The formula is a modification of the classic Wenjing Tang, specifically incorporating *Achyranthes bidentata* (Niuxi) to enhance its ability to conduct blood downward and resolve stasis in the lower jiao. Its primary therapeutic actions include warming the meridians to dispel cold, nourishing the blood, and promoting circulation to alleviate pain. It is clinically indicated for conditions such as secondary amenorrhea, dysmenorrhea, and certain types of infertility. The pharmacological effects are attributed to a synergy of active compounds like ferulic acid, ligustilide, and cinnamaldehyde, which modulate the endocrine system and provide anti-inflammatory and analgesic benefits.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Niuxi Wenjing Tang.